Orapaz
Generic: Cephalexin, Ibuprofen, Chlorhexidine Gluconate
- Manufacturer
- CTS Chemical Industries
- NDC
- 73614-417
- RxCUI
- 197807
- ICD-10 indication
- E72.20
Affordability Check
How much will you actually pay for Orapaz?
In 30 seconds, see every legitimate way to afford Orapaz — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.
About Orapaz
Orapaz is a prescription medication containing the active ingredient donepezil hydrochloride, which belongs to a class of drugs known as cholinesterase inhibitors. It is primarily indicated for the treatment of dementia of the Alzheimer's type. The medication works by preventing the breakdown of acetylcholine in the brain, thereby increasing its levels to help improve memory and cognitive function.
Copay & patient assistance
Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.
External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.
Compare pricing elsewhere
RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.
Cost Plus Drug Company
Mark Cuban's transparent-pricing pharmacy — manufacturer cost + 15% markup + $5 dispensing fee. No insurance needed. Search alphabetically for Cephalexin, Ibuprofen, Chlorhexidine Gluconate.
Browse Cost Plus medications →
GoodRx
Compare local pharmacy prices with GoodRx coupons. Use the price with your insurance or without — whichever is cheaper.
Lookup Orapaz →
NeedyMeds
Independent nonprofit directory of patient assistance programs, copay cards, and charity co-pay foundations.
Search for Cephalexin, Ibuprofen, Chlorhexidine Gluconate →
RxAssist
PAP directory maintained by Volunteers in Health Care at Brown University. Free, no ads.
Search PAPs →
We deep-link because transparency helps patients. None of these partners pay RxCopays.
Conditions we've indexed resources for
Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.
Medicare Part D coverage
How Orapaz appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-04-30).
Covered by plans
60%
3,325 of 5,509 plans
Most common tier
Tier 1
On 87% of covering formularies
Prior authorization required
0%
of covering formularies
| Tier | Formularies on this tier | Share |
|---|---|---|
| Tier 1 (preferred generic) | 287 | 87% |
| Tier 2 (generic) | 38 | 12% |
| Tier 3 (preferred brand) | 2 | 1% |
| Tier 6 | 2 | 1% |
Step therapy: 0% of formularies
Quantity limits: 16% of formularies
Coverage breadth: 329 of 65 formularies
How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).
Prior authorization & coverage
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
Related drugs
Glycerol Phenylbutyrate
Treats same condition · glycerol phenylbutyrate
Sodium Phenylbutyrate
Treats same condition · Sodium Phenylbutyrate
Carbaglu
Treats same condition · Carglumic Acid
Ravicti
Treats same condition · glycerol phenylbutyrate
SODIUM PHENYLACETATE AND SODIUM BENZOATE
Treats same condition · sodium phenylacetate and sodium benzoate
PHEBURANE
Treats same condition · Sodium phenylbutyrate
BUPHENYL, Buphenyl
Treats same condition
How this page is sourced
- Drug identity verified against openFDA NDC Directory.
- Label text (when shown) originates from NLM DailyMed.
- Copay and assistance URLs verified periodically; if you hit a broken link, tell us.